Association of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?
- 26 December 2019
- journal article
- editorial
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (4), e1901-e1902
- https://doi.org/10.1210/clinem/dgz305
Abstract
Elif Hindié, Kenneth B Ain, Slimane Zerdoud, Anca M Avram; Association of Radioactive Iodine Treatment of Hyperthyroidism with Cancer Mortality: an UnjustifiedKeywords
This publication has 7 references indexed in Scilit:
- Spotlight on the Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism is Keeping the Highest Risk From Antithyroid Drugs in the Blind SpotClinical Nuclear Medicine, 2019
- Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With HyperthyroidismJAMA Internal Medicine, 2019
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of ThyrotoxicosisThyroid®, 2016
- Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for HyperthyroidismJournal of Clinical Endocrinology & Metabolism, 2015
- Comparison of Mortality in Hyperthyroidism During Periods of Treatment With Thionamides and After RadioiodineJournal of Clinical Endocrinology & Metabolism, 2013
- Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort studyThe Lancet, 1999
- Cancer Mortality Following Treatment for Adult HyperthyroidismJAMA, 1998